Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Vanguard Personalized Indexing Management LLC

Vanguard Personalized Indexing Management LLC raised its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 7.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,354 shares of the biotechnology company’s stock after acquiring an additional 462 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Axon Enterprise were worth $1,843,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. 9258 Wealth Management LLC purchased a new stake in shares of Axon Enterprise in the fourth quarter worth about $204,000. Principal Securities Inc. purchased a new stake in Axon Enterprise in the 4th quarter worth approximately $49,000. Beacon Pointe Advisors LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter worth approximately $218,000. Robeco Institutional Asset Management B.V. increased its holdings in shares of Axon Enterprise by 1,049.8% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 59,319 shares of the biotechnology company’s stock valued at $153,000 after purchasing an additional 54,160 shares in the last quarter. Finally, PNC Financial Services Group Inc. lifted its stake in shares of Axon Enterprise by 11.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 4,320 shares of the biotechnology company’s stock valued at $1,116,000 after purchasing an additional 427 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $373.03, for a total value of $167,863.50. Following the transaction, the director now directly owns 7,379 shares of the company’s stock, valued at approximately $2,752,588.37. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Matthew R. Mcbrady sold 2,000 shares of the company’s stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $364.66, for a total value of $729,320.00. Following the completion of the sale, the director now owns 4,892 shares of the company’s stock, valued at $1,783,916.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $373.03, for a total transaction of $167,863.50. Following the sale, the director now owns 7,379 shares of the company’s stock, valued at $2,752,588.37. The disclosure for this sale can be found here. In the last quarter, insiders sold 317,981 shares of company stock valued at $115,662,734. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Up 0.9 %

Shares of AXON opened at $393.29 on Friday. The stock has a 50 day moving average price of $348.04 and a 200 day moving average price of $317.22. Axon Enterprise, Inc. has a one year low of $189.12 and a one year high of $393.58. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.52 and a current ratio of 2.88. The stock has a market capitalization of $29.72 billion, a price-to-earnings ratio of 115.00, a PEG ratio of 10.34 and a beta of 0.94.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. The business had revenue of $504.00 million during the quarter, compared to analyst estimates of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The company’s revenue for the quarter was up 34.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.80 earnings per share. Equities research analysts forecast that Axon Enterprise, Inc. will post 1.79 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently commented on AXON. Northland Securities raised their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a research report on Thursday, August 8th. JMP Securities raised their target price on Axon Enterprise from $375.00 to $430.00 and gave the company an “outperform” rating in a research report on Thursday, September 12th. Bank of America assumed coverage on Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $380.00 price target for the company. Needham & Company LLC reissued a “buy” rating and issued a $400.00 price objective on shares of Axon Enterprise in a report on Wednesday, August 7th. Finally, Jefferies Financial Group began coverage on Axon Enterprise in a research note on Wednesday, July 17th. They set a “buy” rating and a $385.00 target price for the company. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus price target of $365.38.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.